MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$3K
Net Income
-$699K
Net Profit Margin
-23300.00%
EPS
-$0.01
Unit: Thousand (K) dollars
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
3
7
-5*
18
Cost of revenue
1
-
415*
1
Sales, general and administrative compensation (inclusive of stock-based compensation)
167
1,620
113*
261
Sales and marketing
-
1
20*
2
Professional fees
92
258
38*
234
Research and development
76
46
150*
52
Depreciation and amortization
284
285
281*
288
Rent and utilities
18
19
19*
19
Loss on disposal of fixed assets
-
-
-3*
-
Other operating expenses
67
67
89*
109
Total costs and expenses
705
2,296
1,125*
966
Operating loss
-702
-2,289
-1,130*
-948
Interest income
-
-
4*
3
Change in fair value of note payable, related party
-
-
-10,427*
268
Interest expense
-
-
10*
262
Interest income
2
5
-
-
Gain from operations before income taxes
-700
-2,284
9,291*
-1,475
Income tax benefit (expense)
-
-
-2,580*
-
Net gain
-700
-2,284
11,871*
-1,475
Loss (income) from operations attributed to noncontrolling interest
-1
3
-15*
-5
Net gain attributable to common stockholders
-699
-2,287
11,886
-1,470
Basic EPS
-0.01
-0.02
0.169
-0.12
Diluted EPS
-0.01
-0.02
-0.095*
-0.12
Basic Average Shares
107,821,231
107,785,675
70,280,547
12,185,412
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net gainattributable to common...-$699K (95.13%↑ Y/Y)Loss (income) fromoperations attributed to...-$1K (83.33%↑ Y/Y)Net gain-$700K (95.12%↑ Y/Y)Gain from operationsbefore income taxes-$700K (95.12%↑ Y/Y)Interest income$2K (-33.33%↓ Y/Y)Operating loss-$702K (39.12%↑ Y/Y)Total revenue$3K (-57.14%↓ Y/Y)Total costs andexpenses$705K (-39.22%↓ Y/Y)Depreciation andamortization$284K (-1.39%↓ Y/Y)Sales, general andadministrative compensation...$167K (-32.11%↓ Y/Y)Professional fees$92K (-77.62%↓ Y/Y)Research and development$76K (1.33%↑ Y/Y)Other operatingexpenses$67K (-39.09%↓ Y/Y)Rent and utilities$18K (0.00%↑ Y/Y)Cost of revenue$1K (-90.91%↓ Y/Y)

IMPACT BIOMEDICAL INC. (IBO)

IMPACT BIOMEDICAL INC. (IBO)